Article
New therapeutic axis in blood malignancies involving microRNAs and JAK/STAT3 signaling
2023-11-16
Abstract excerpt
Cancers of the blood stemming from genetic or environmental abnormalities are included in the broad category of blood diseases. Some forms of leukemia may respond better to therapy than others, and there are a number of factors that contribute to the failure of current medications to effectively address blood diseases, including drug resistance. Many different factors, both inherited and acquired, may cause leukem...
Topics
Open a Topic to create a Post that cites this publication.
- Cancer Mechanisms and Therapy
- Cancer-related molecular mechanisms research
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Cytokine Signaling Pathways and Interactions
- Kruppel-like factors research
- MicroRNA in disease regulation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Identifiers and source
- Literature Corpus work
- 6800a765-b1f5-52db-91ea-3593cd051a93
- DOI
- 10.22541/au.170016203.37107299/v1